ALPS Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,811
| Closed | -$106K | – | 1038 |
|
|
2025
Q1 | $106K | Sell |
32,811
-4,568
| -12% | -$14.8K | ﹤0.01% | 978 |
|
|
2024
Q4 | $208K | Sell |
37,379
-1,964
| -5% | -$10.9K | ﹤0.01% | 971 |
|
|
2024
Q3 | $425K | Sell |
39,343
-1,012
| -3% | -$10.9K | ﹤0.01% | 630 |
|
|
2024
Q2 | $847K | Buy |
40,355
+5,246
| +15% | +$110K | 0.01% | 501 |
|
|
2024
Q1 | $1.12M | Buy |
35,109
+6,077
| +21% | +$194K | 0.01% | 448 |
|
|
2023
Q4 | $588K | Buy |
+29,032
| New | +$588K | ﹤0.01% | 579 |
|
|
2022
Q4 | – | Sell |
-17,663
| Closed | -$142K | – | 1049 |
|
|
2022
Q3 | $142K | Sell |
17,663
-1,492
| -8% | -$12K | ﹤0.01% | 1021 |
|
|
2022
Q2 | $134K | Buy |
+19,155
| New | +$134K | ﹤0.01% | 1018 |
|